How many studies have been conducted on Adenosine 5 N Ethylcarboxamide?

BiohacksAI has indexed 32 PubMed studies on Adenosine 5 N Ethylcarboxamide. 3% of studies involve human subjects.

What are the main research areas for Adenosine 5 N Ethylcarboxamide?

The primary research domains for Adenosine 5 N Ethylcarboxamide are 🌤️ Mood & Depression, 🔬 Oncology, 🧬 Hormones. This is based on analysis of 32 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Adenosine 5 N Ethylcarboxamide

A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity.

32+ PubMed studies analyzed · Evidence Score: 38.6

Research Domains

Adenosine 5 N Ethylcarboxamide has been studied across 13 research domains including 🌤️ Mood & Depression, 🔬 Oncology, 🧬 Hormones, 🔥 Metabolic, 🔬 Inflammation. The primary research focus is 🌤️ Mood & Depression with 19% of studies addressing this area.

Loading evidence profile...

This evidence profile for Adenosine 5 N Ethylcarboxamide is generated deterministically from 32 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.